Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT04561206 |
Title | Brentuximab Vedotin and Nivolumab for the Treatment of Patients With Relapsed Classical Hodgkin Lymphoma |
Recruitment | Recruiting |
Gender | both |
Phase | Phase II |
Variant Requirements | No |
Sponsors | City of Hope Medical Center |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
City of Hope Medical Center | RECRUITING | Duarte | California | 91010 | United States | Details |
University of Chicago Cancer Research Center | RECRUITING | Chicago | Illinois | 60637 | United States | Details |
Dana-Farber Cancer Institute | RECRUITING | Boston | Massachusetts | 02215 | United States | Details |
Hackensack University Medical Center/John Theurer Cancer Center | RECRUITING | Hackensack | New Jersey | 07601 | United States | Details |
Sarah Cannon Research Institute | RECRUITING | Nashville | Tennessee | 37203 | United States | Details |